Grove Ventures

Quantum Source is developing a novel photonic quantum architecture for fault-tolerant, practical quantum computers. Their approach uses chip-based photon-atom gates to enable deterministic exchange of quantum information between photonic and atomic qubits. This allows for scalable quantum systems with reduced complexity, footprint, power consumption, and cost compared to other implementations.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

NoTraffic is a technology company that specializes in transforming traditional traffic intersections into smart, connected networks. Its platform optimizes traffic flow, prioritizes various vehicles, and enhances safety by leveraging AI sensors for real-time road user detection and classification. Established in 2016, NoTraffic operates globally with strategic partnerships to accelerate its rollout.

Deepchecks develops a machine learning monitoring platform designed to oversee the performance and stability of artificial intelligence systems. It specializes in an open-source testing framework that adheres to best practices, enabling clients to release large language model applications swiftly without compromising on thorough testing.

Quantum Source is developing a novel photonic quantum architecture for fault-tolerant, practical quantum computers. Their approach uses chip-based photon-atom gates to enable deterministic exchange of quantum information between photonic and atomic qubits. This allows for scalable quantum systems with reduced complexity, footprint, power consumption, and cost compared to other implementations.

Quantum Source is developing a novel photonic quantum architecture for fault-tolerant, practical quantum computers. Their approach uses chip-based photon-atom gates to enable deterministic exchange of quantum information between photonic and atomic qubits. This allows for scalable quantum systems with reduced complexity, footprint, power consumption, and cost compared to other implementations.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

Lumigo Ltd. is a technology company that focuses on developing a serverless intelligence platform designed to assist developers in monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and headquartered in Tel Aviv, Israel, Lumigo's platform leverages data analysis to learn the normal behavior of serverless applications, providing live visual maps and insights that help identify and resolve issues quickly. The platform offers end-to-end visibility and traceability, allowing operations teams to understand each request and pinpoint the root causes of problems, including interactions with adjacent services like databases and storage. By enabling actionable alerts based on user behavior analytics, Lumigo empowers organizations to prevent service disruptions and enhance the reliability of their cloud applications.

NeuroBlade is an Israeli technology company that develops AI inference processors and computational memory-based solutions to accelerate analytics for data centers and end devices. Its hardware and software stack is designed to support any AI topology while addressing memory bottlenecks, enabling faster analytics and reduced time to insights. The company leverages proprietary computational memory technology and expertise in hardware, software, and algorithms to lower costs and power consumption compared with traditional accelerators. Founded in the late 2010s, NeuroBlade is headquartered in Tel Aviv with operations in Taipei and Palo Alto, reflecting a global footprint. The company aims to redefine analytics acceleration for large data workloads by delivering high-performance, energy-efficient processing that improves query performance across enterprise applications.

NoTraffic is a technology company that specializes in transforming traditional traffic intersections into smart, connected networks. Its platform optimizes traffic flow, prioritizes various vehicles, and enhances safety by leveraging AI sensors for real-time road user detection and classification. Established in 2016, NoTraffic operates globally with strategic partnerships to accelerate its rollout.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

Founded in 2013, Teramount specializes in manufacturing Photonic-Plugs, innovative solutions for connecting optics to silicon in semiconductor manufacturing. Based in Jerusalem, Israel, the company enables standard semiconductor processes and packaging flow in silicon photonics.

BeyondMinds Ltd. is a technology company specializing in the development of artificial intelligence (AI)-based software aimed at facilitating enterprise product deployments. Founded in 2018 and headquartered in Tel Aviv-Yafo, Israel, with additional offices in New York and London, BeyondMinds has created a production-centric AI platform designed to address the challenges of real-world application of AI solutions. The company's Modular Engine supports various business sectors, including finance, industry, and government, by providing customized, production-ready AI systems. This approach aims to reduce the high failure rates associated with AI adoption, enabling organizations to implement sustainable and ROI-positive transformations effectively.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

NeuroBlade is an Israeli technology company that develops AI inference processors and computational memory-based solutions to accelerate analytics for data centers and end devices. Its hardware and software stack is designed to support any AI topology while addressing memory bottlenecks, enabling faster analytics and reduced time to insights. The company leverages proprietary computational memory technology and expertise in hardware, software, and algorithms to lower costs and power consumption compared with traditional accelerators. Founded in the late 2010s, NeuroBlade is headquartered in Tel Aviv with operations in Taipei and Palo Alto, reflecting a global footprint. The company aims to redefine analytics acceleration for large data workloads by delivering high-performance, energy-efficient processing that improves query performance across enterprise applications.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

Lumigo Ltd. is a technology company that focuses on developing a serverless intelligence platform designed to assist developers in monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and headquartered in Tel Aviv, Israel, Lumigo's platform leverages data analysis to learn the normal behavior of serverless applications, providing live visual maps and insights that help identify and resolve issues quickly. The platform offers end-to-end visibility and traceability, allowing operations teams to understand each request and pinpoint the root causes of problems, including interactions with adjacent services like databases and storage. By enabling actionable alerts based on user behavior analytics, Lumigo empowers organizations to prevent service disruptions and enhance the reliability of their cloud applications.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

NeuroBlade is an Israeli technology company that develops AI inference processors and computational memory-based solutions to accelerate analytics for data centers and end devices. Its hardware and software stack is designed to support any AI topology while addressing memory bottlenecks, enabling faster analytics and reduced time to insights. The company leverages proprietary computational memory technology and expertise in hardware, software, and algorithms to lower costs and power consumption compared with traditional accelerators. Founded in the late 2010s, NeuroBlade is headquartered in Tel Aviv with operations in Taipei and Palo Alto, reflecting a global footprint. The company aims to redefine analytics acceleration for large data workloads by delivering high-performance, energy-efficient processing that improves query performance across enterprise applications.